Funding for this research was provided by:
Versus Arthritis (21810)
Medical Research Council (MR/T001631/1)
Received: 2 March 2021
Accepted: 26 July 2021
First Online: 6 September 2021
: Strict adherence to institutional guidelines was practiced, and full local ethics committee and Home Office approval were obtained prior to all animal procedures.
: Not applicable.
: OL, PB, JLJ and IK are employees of Inventiva. CD reports grants and personal fees from GSK, personal fees from Boerhinger Ingelheim, grants from Servier, grants and personal fees from Inventiva, grants and personal fees from Arxx Therapeutics, personal fees from Corbus, personal fees from Sanofi and personal fees from Roche. The other authors declare that they have no competing interests.